On Demand CE: Antiplatelet Therapy in the High Risk Cardiovascular Patient

Optimizing Antiplatelet Therapy in the High Risk CVD Patient

With 1.7 million hospital discharges per year, acute coronary syndrome constitutes a significant burden of health. In this on-demand CE course, you will learn the classes of anti-platelet therapies, review clinical trial data, learn about guideline-based use, and hear case presentations. 

Credit: 1.0 CE contact hours, 1.0 Pharmacology 
Cost: free

Take this Course


  • David Anderson MS, MD, FACC, FSCAI

Upon completion of this activity, participants will be able to: 

  • Identify the guidelines for dual antiplatelet therapy in the post-ACS patient
  • Identify the indications in which the risk of ASCFD outweighs the risk of bleeding, justifying the addition of a PAR-1 antagonist to standard dual oral antiplatelet therapy
  • List three classes of antiplatelet agents
This educational activity is provided by the Preventive Cardiovascular Nurses Association (PCNA). PCNA is accredited by the American Association of Nurse Practitioners (AANP) as an approved provider of Nurse Practitioner continuing education, provider number 030602.